Patents by Inventor Adam Elhofy

Adam Elhofy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF IMMUNE EVASIVE TUMORS
    Publication number: 20220257768
    Abstract: The present disclosure provides methods of treating immune evasive cancers using surface functionalized particles alone or in combination with cancer therapeutics.
    Type: Application
    Filed: July 31, 2020
    Publication date: August 18, 2022
    Inventors: John PUISIS, Adam ELHOFY, Tushar MURTHY, Michael BOYNE, Joseph PODOJIL
  • Compositions and Methods for Treatment of Fibrosis
    Publication number: 20200246361
    Abstract: The present disclosure relates, in general, to compositions comprising phosphatidylcholine and phosphatidylcholine derivatives, e.g., DLPC (1, 2-dilauroyl-sn-glycero-3-phosphocholine) or DPPC, for the treatment of fibrosis, including liver fibrosis and associated conditions such as fatty liver disease, non-alcoholic steatohepatitis (NASH) and cirrhosis, or lung fibrosis and conditions associated with lung fibrosis.
    Type: Application
    Filed: October 11, 2018
    Publication date: August 6, 2020
    Inventor: Adam Elhofy
  • Media for Cell Culture
    Publication number: 20170198251
    Abstract: The present disclosure relates, in general, to a media, e.g., a serum replacement, media supplement, complete media or cryopreservation media, comprising a base physiological buffer and liposomes comprising cholesterol, phosphatidylcholine and fatty acids. It is contemplated that media provides advantages to improve cell growth in culture compared to cells cultured not using the serum replacement described herein.
    Type: Application
    Filed: March 28, 2017
    Publication date: July 13, 2017
    Inventors: Adam Elhofy, Allan Weber
  • Media for cell culture
    Patent number: 9637721
    Abstract: The present disclosure relates, in general, to a media, e.g., a serum replacement, media supplement, complete media or cryopreservation media, comprising a base physiological buffer and liposomes comprising cholesterol, phosphatidylcholine and fatty acids. It is contemplated that media provides advantages to improve cell growth in culture compared to cells cultured not using the serum replacement described herein.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: May 2, 2017
    Assignee: BIO-ESS LABORATORIES, LLC.
    Inventors: Adam Elhofy, Allan Weber
  • Media for Cell Culture
    Publication number: 20150175956
    Abstract: The present disclosure relates, in general, to a media, e.g., a serum replacement, media supplement, complete media or cryopreservation media, comprising a base physiological buffer and liposomes comprising cholesterol, phosphatidylcholine and fatty acids. It is contemplated that media provides advantages to improve cell growth in culture compared to cells cultured not using the serum replacement described herein.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 25, 2015
    Inventors: Adam Elhofy, Allan Weber